3[14]Murpty GP, Barren RJ, Erickson SJ ,et al. Evaluation and comparison of two new prostate carcinoma markers:Free prostate specific antigen and prostale specific membrane antigen [J].Cancer. 1996,78:809～818.
4[16]G.H.Liu, J.Wu, Free PSA from mormal seminal plasma is different from free PSA from a prostate cancer cell line (LN CaP.cell time)[J].Clinical Chemistry.vol.46,No 6,Supplement,2000.A155.
5[17]P.Datta, K.TasaicoE valuation of equimolarity betwwn free and ACT-Complexed PSA with a new automated chemiluminesent PSA assay[J].Clinical Chemistry.vol.46,supplement,2000 A163.
6[18]C.D.Cheli, I Neaman, J.L. Goldblatt, et al. Lack of "PSA GAP"using the Bayer Immuno I Complexed PSA assay [J].Clin Chem,Vol.46,NO.6,supplement,2000:A 157.
7[19]Z.Zhou, Y.Chen, A.Belenky, et al. Fully antomated immunoassay for the measurement of PSA-ACT:its accuracy and clinical uilliy. Clin Chem,Vol.46,NO.46,supplement,2000:A168.
8[20]C.D.Cheli, L.F.Ferreri, et al. Complexed PSA and complexed total PSA ratio for early detection of prostate cancer in men with serum PSA 2 -4ng/ml [J].Clinical Chemistry,Vol.46,supplement,2000:A 157.
9[21]M.Hussain, l.E.Neaman, J.Goldblatt, et al. Risk predictim of prostate cancer using logistic uegression based in complexed PSA, total PSA, digital rectal eramination(PRE),age, and heredity as explanatory variabres [J].Coin Chem,Vol.46,No.6,supplement,2000:A 168.
10[22]H.A. Fritsche, R.J.Babaian, et al. A neural network derived algorithm for the early detection of prostate cance [J].Clinical Chemistry,vol.46, NO.6,supplement,2000:A 166.
